HuagongsheHuagongshe Chemistry Print Report · For research reference only
(2-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)(morpholino)methanone → [4-(2-{4-[4-(2-Methoxy-ethyl)-piperazin-1-yl]-3-methyl-phenylamino}-benzooxazol-7-yl)-2-methyl-phenyl]-morpholin-4-yl-methanone
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | (2-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)(morpholino)methanone | HCID 59392731 | — |
| Reactant | (7-Bromo-benzooxazol-2-yl)-{4-[4-(2-methoxy-ethyl)-piperazin-1-yl]-3-methyl-phenyl}-amine | HCID 67457843 | — |
| Product | [4-(2-{4-[4-(2-Methoxy-ethyl)-piperazin-1-yl]-3-methyl-phenylamino}-benzooxazol-7-yl)-2-methyl-phenyl]-morpholin-4-yl-methanone | HCID 59144237 | — |
Reaction Steps
The title compound is prepared from (7-bromo-benzooxazol-2-yl)-{4-[4-(2-methoxy-ethyl)-piperazin-1-yl]-3-methyl-phenyl}-amine and [2-methyl-4-(4,4,5,5-tetramethyl-[1,3,2]dioxa-borolan-2-yl)-phenyl]-morpholin-4-yl-methanone using methodology described in the preparation of example 65. The title compound is obtained as an off-white foam. Rt=2.00 min (Waters Symmetry C8, 2.1×50 mm, detection 210-250 nM, 5% to 100% CH3CN in H2O in 2 min+0.05% TFA, flow rate 1.0 ml/min); MS: 570 (M+1)+.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08629168B2 |
| Source dataset | uspto-grants-2014_01 |
| ORD ID | ord-501fbf14a33b4b818628bc407fbbcfec |
| Source note | uspto-grants-2014_01 |